masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.
Company profile
Ticker
MASI
Exchange
Website
CEO
Joseph Kiani
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Natus Medical • LivaNova • BioPlus Acquisition • GigCapital5 • Outset Medical • Fonar ...
SEC CIK
Corporate docs
Subsidiaries
Masimo Americas, Inc. • Masimo de Mexico Holdings I LLC • Masimo de Mexico Holdings II LLC • Masimo Holdings LLC • SpO2.com, Inc. • SEDLine, Inc. • Masimo Australia Pty Ltd • Masimo Öesterreich GmbH • Masimo Importacao e Distribuicao de Produtos Medicos Ltda • Masimo Holdings LP ...
IRS number
330368882
MASI stock data
Analyst ratings and price targets
Latest filings (excl ownership)
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
Masimo Reports Second Quarter 2023 Financial Results
8 Aug 23
8-K
Masimo Announces Preliminary Second Quarter 2023 Revenue Results
17 Jul 23
8-K
Departure of Directors or Certain Officers
28 Jun 23
DEFA14A
Additional proxy soliciting materials
23 Jun 23
DEFA14A
Additional proxy soliciting materials
22 Jun 23
DEFA14A
Additional proxy soliciting materials
20 Jun 23
DEFA14A
Additional proxy soliciting materials
20 Jun 23
DFAN14A
Additional proxy materials by non-management
15 Jun 23
DFAN14A
Additional proxy materials by non-management
13 Jun 23
Transcripts
MASI
Earnings call transcript
2023 Q2
8 Aug 23
MASI
Earnings call transcript
2023 Q1
9 May 23
MASI
Earnings call transcript
2022 Q4
28 Feb 23
MASI
Earnings call transcript
2022 Q3
9 Nov 22
MASI
Earnings call transcript
2022 Q2
10 Aug 22
MASI
Earnings call transcript
2022 Q1
3 May 22
MASI
Earnings call transcript
2021 Q4
16 Feb 22
MASI
Earnings call transcript
2021 Q3
27 Oct 21
MASI
Earnings call transcript
2021 Q2
28 Jul 21
MASI
Earnings call transcript
2021 Q1
27 Apr 21
Latest ownership filings
Financial summary
| Quarter (USD) | Jul 23 | Apr 23 | Dec 22 | Oct 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Jan 22 | Jan 21 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 158.60 mm | 158.60 mm | 158.60 mm | 158.60 mm | 158.60 mm | 158.60 mm |
| Cash burn (monthly) | 7.50 mm | 5.17 mm | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 21.21 mm | 14.61 mm | n/a | n/a | n/a | n/a |
| Cash remaining | 137.39 mm | 143.99 mm | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 18.3 | 27.9 | n/a | n/a | n/a | n/a |
Institutional ownership, Q2 2023
85.9% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 398 |
| Opened positions | 49 |
| Closed positions | 64 |
| Increased positions | 106 |
| Reduced positions | 163 |
| 13F shares | Current |
|---|---|
| Total value | 7.45 tn |
| Total shares | 45.35 mm |
| Total puts | 34.80 k |
| Total calls | 180.60 k |
| Total put/call ratio | 0.2 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 7.16 mm | $1.18 tn |
| BLK Blackrock | 6.12 mm | $1.01 tn |
| Vanguard | 4.86 mm | $798.93 bn |
| Politan Capital Management | 4.71 mm | $775.61 bn |
| STT State Street | 1.66 mm | $273.94 bn |
| Capital Research Global Investors | 1.65 mm | $271.92 bn |
| RTW Investments | 1.50 mm | $247.07 bn |
| Westfield Capital Management | 953.80 k | $156.95 bn |
| Liontrust Investment Partners | 920.41 k | $151.45 bn |
| Geode Capital Management | 758.61 k | $124.64 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 11 Aug 23 | Masimo | Common Stock | Conversion | Acquire C | No | No | 0 | 531,548 | 0.00 | 531,548 |
| 11 Aug 23 | Masimo | Pre-Funded Warrant, Common Stock Common Stock | Conversion | Acquire C | No | No | 0.0005 | 289,779 | 144.89 | 289,779 |
| 11 Aug 23 | Masimo | Pre-Funded Warrant, Series A Preferred Stock Series A Preferred Stock | Conversion | Dispose C | No | No | 0.0001 | 144,890 | 14.49 | 0 |
| 11 Aug 23 | Masimo | Series A Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 265,774 | 0.00 | 0 |
| 10 Aug 23 | Masimo | Common Stock | Conversion | Acquire C | No | No | 0 | 531,548 | 0.00 | 531,548 |
| 10 Aug 23 | Masimo | Pre-Funded Warrant, Common Stock Common Stock | Conversion | Acquire C | No | No | 0.0005 | 289,779 | 144.89 | 289,779 |
| 10 Aug 23 | Masimo | Pre-Funded Warrant, Series A Preferred Stock Series A Preferred Stock | Conversion | Dispose C | No | No | 0.0001 | 144,890 | 14.49 | 0 |
| 10 Aug 23 | Masimo | Series A Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 265,774 | 0.00 | 0 |
| 26 Jun 23 | Reynolds Craig B | RSU Common Stock | Grant | Acquire A | No | No | 0 | 1,228 | 0.00 | 1,228 |
| 26 Jun 23 | Mikkelson Adam | RSU Common Stock | Grant | Acquire A | No | No | 0 | 1,228 | 0.00 | 1,228 |
News
10 Health Care Stocks Whale Activity In Today's Session
18 Sep 23
Stocks That Hit 52-Week Lows On Monday
11 Sep 23
Wells Fargo Maintains Equal-Weight on Masimo, Lowers Price Target to $110
9 Aug 23
What 7 Analyst Ratings Have To Say About Masimo
9 Aug 23
Needham Reiterates Buy on Masimo, Maintains $136 Price Target
9 Aug 23
Press releases
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Masimo Corporation (MASI)
25 Sep 23
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hawaiian Electric, Masimo, and Origin and Encourages Investors to Contact the Firm
22 Sep 23
MASI Investors Have Opportunity to Lead Masimo Corporation Securities Fraud Lawsuit
22 Sep 23
MASIMO DEADLINE REMINDER : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Masimo To Contact Him Directly To Discuss Their Options
21 Sep 23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Masimo Corporation - MASI
21 Sep 23